ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

被引:129
作者
Colombo, Nicoletta [1 ,2 ]
Creutzberg, Carien [3 ]
Amant, Frederic [4 ,5 ]
Bosse, Tjalling [6 ]
Gonzalez-Martin, Antonio [7 ,8 ]
Ledermann, Jonathan [9 ]
Marth, Christian [10 ]
Nout, Remi [11 ]
Querleu, Denis [12 ,13 ]
Mirza, Mansoor Raza [14 ]
Sessa, Cristiana [15 ]
机构
[1] European Inst Oncol, Div Med Gynecol Oncol, Milan, Italy
[2] Univ Milano Bicocca, Milan, Italy
[3] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[4] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium
[5] CGOA, Amsterdam, Netherlands
[6] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[7] GEICO, Dept Med Oncol, Madrid, Spain
[8] MD Anderson Canc Ctr, Madrid, Spain
[9] UCL Canc Inst, Dept Oncol & Canc Trials, London, England
[10] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[11] Leiden Univ, Dept Radiotherapy, Med Ctr, Leiden, Netherlands
[12] Inst Bergonie, Dept Surg, Bordeaux, France
[13] McGill Univ, Dept Gynecol & Obstet, Ctr Hlth, Montreal, PQ, Canada
[14] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
[15] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, Dept Med Oncol, Bellinzona, Switzerland
关键词
Endometrial neoplasms; Practice guideline; Consensus; Treatment; Adjuvant; Surgery; PHASE-III TRIAL; LYMPHVASCULAR SPACE INVOLVEMENT; FERTILITY-SPARING-MANAGEMENT; POSTOPERATIVE RADIATION-THERAPY; WHOLE-ABDOMINAL-IRRADIATION; EXTERNAL-BEAM RADIOTHERAPY; UTERINE SEROUS CARCINOMA; INDEPENDENT RISK-FACTOR; CLINICAL STAGE-I; CLEAR-CELL;
D O I
10.1016/j.radonc.2015.11.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy 82 Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article. (C) 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:559 / 581
页数:23
相关论文
共 214 条
[1]   Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group [J].
Aapro, MS ;
van Wijk, FH ;
Bolis, G ;
Chevallier, B ;
van der Burg, MEL ;
Poveda, A ;
de Oliveira, CF ;
Tumolo, S ;
di Palumbo, VS ;
Piccart, M ;
Franchi, M ;
Zanaboni, F ;
Lacave, AJ ;
Fontanelli, R ;
Favalli, G ;
Zola, P ;
Guastalla, JP ;
Rosso, R ;
Marth, C ;
Nooij, M ;
Presti, M ;
Scarabelli, C ;
Splinter, TAW ;
Ploch, E ;
Beex, LVA ;
Huinink, WT ;
Forni, M ;
Melpignano, M ;
Blake, P ;
Kerbrat, P ;
Mendiola, C ;
Cervantes, A ;
Goupil, A ;
Harper, PG ;
Madronal, C ;
Namer, M ;
Scarfone, G ;
Stoot, JEGM ;
Teodorovic, I ;
Coens, C ;
Vergote, I ;
Vermorken, JB .
ANNALS OF ONCOLOGY, 2003, 14 (03) :441-448
[2]   Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Approach to Surgical Staging [J].
Abu-Rustum, Nadeem R. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (02) :288-297
[3]   The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes [J].
Abu-Rustum, Nadeem R. ;
Gomez, Jacob D. ;
Alektiar, Kaled M. ;
Soslow, Robert A. ;
Hensley, Martee L. ;
Leitao, Mario M., Jr. ;
Gardner, Ginger J. ;
Sonoda, Yukio ;
Chi, Dennis S. ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2009, 115 (02) :236-238
[4]   Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? [J].
Abu-Rustum, Nadeem R. ;
Iasonos, Alexia ;
Zhou, Qin ;
Oke, Eniola ;
Soslow, Robert A. ;
Alektiar, Kaled M. ;
Chi, Dennis S. ;
Barakat, Richard R. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) :457.e1-457.e6
[5]   A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P. [J].
Aghajanian, Carol ;
Filiaci, Virginia L. ;
Dizon, Don S. ;
Carlson, Jay ;
Powell, Matthew A. ;
Secord, Angeles Alvarez ;
Tewari, Krishnansu Sujata ;
Bender, David ;
O'Malley, David M. ;
Stuckey, Ashley ;
Rotmensch, Jacob ;
Levine, Douglas A. ;
Lankes, Heather A. ;
Moore, Kathleen N. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[6]   Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study [J].
Aghajanian, Carol ;
Sill, Michael W. ;
Darcy, Kathleen M. ;
Greer, Benjamin ;
McMeekin, D. Scott ;
Rose, Peter G. ;
Rotmensch, Jacob ;
Barnes, Mack N. ;
Hanjani, Parviz ;
Leslie, Kimberly K. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :2259-2265
[7]   WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma [J].
Al-Hussaini, M ;
Stockman, A ;
Foster, H ;
McCluggage, WG .
HISTOPATHOLOGY, 2004, 44 (02) :109-115
[8]   Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer [J].
AlHilli, Mariam M. ;
Mariani, Andrea ;
Bakkum-Gamez, Jamie N. ;
Dowdy, Sean C. ;
Weaver, Amy L. ;
Peethambaram, Preema P. ;
Keeney, Gary L. ;
Cliby, William A. ;
Podratz, Karl C. .
GYNECOLOGIC ONCOLOGY, 2014, 133 (03) :485-493
[9]   Reproductive Factors and the Risk of Endometrial Cancer [J].
Ali, Aus Tariq .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) :384-393
[10]   PAX2 Loss by Immunohistochemistry Occurs Early and Often in Endometrial Hyperplasia [J].
Allison, Kimberly H. ;
Upson, Kristen ;
Reed, Susan D. ;
Jordan, Carolyn D. ;
Newton, Katherine M. ;
Doherty, Jennifer ;
Swisher, Elizabeth M. ;
Garcia, Rochelle L. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (02) :159-167